Lilly builds Suzhou plant
Print Edition
ELI Lilly & Co started building its third manufacturing plant in Suzhou, Jiangsu Province, yesterday, with the United States pharmaceutical giant saying it will continue a robust investment pace in China although it is downsizing its footprint in other regions.
Located in the Suzhou Industrial Park, the project involves a total investment of 2 billion yuan (US$322 million), about three times the total that Lilly has invested in Suzhou.
“The new project is an evidence that we are going to continue to invest in China in a very robust way even though we’re facing difficulties in other markets,” said John C. Lechleiter, chief executive officer of Lilly.
The Indianapolis-based firm has been making cutbacks in the US and Europe as it deals with the loss of patent protection for some of its top drugs.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
